Guardant Health Inc · Transaction Nov 21, 2025 · Filed Dec 1, 2025 · $1,001 to $15,000
XNAS · GH
+1.94% · +$3.39 · Vol 525.9K
Live · updated 11:52:48 ET
Guardant Health, Inc. Common Stock
SERVICES-MEDICAL LABORATORIES
$178.14
Follow $GH
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $GH by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredThu Oct 1 · last completed session · daily score · 17h old · GH
MethodologyGH
Guardant Health, Inc. Common Stock
Thu Oct 1 · last completed session · daily score · 17h old
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
45/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Thu Oct 1 · last completed session · daily score · 17h old
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is GH moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Guardant Health, Inc. Common Stock
SERVICES-MEDICAL LABORATORIESListed since
2018
Employees
3K
Country
US
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$173.32
Day high
$178.94
Day low
$172.00
Previous close
$174.75
52W high
$183.10
-2.71% from high
52W low
$61.46
96% of range
Market cap
$23.5B
EPS
$-3.3200
Beta
0.61
Shares out
134.2M
Volume
525.9K
0.28× rel vol
Avg volume
1.9M
VWAP
$176.54
Price history computed in-house
1W
+0.50%
1M
+9.25%
3M
+6.05%
1Y
+189.85%
YTD
+74.41%
SMA 50 $164.78 · above
SMA 200 $123.56 · above
52W position 96%
GH overview
Related filings and maps
Public disclosures
Congress activity in GH
Official filing ↗
Disclosed security · Transaction Feb 28, 2022 · Filed Mar 3, 2022 · $1,001 to $15,000
Disclosed security · Transaction Jan 13, 2022 · Filed Feb 1, 2022 · $1,001 to $15,000
Disclosed security · Transaction Dec 22, 2021 · Filed Jan 1, 2022 · $1,001 to $15,000
Disclosed security · Transaction Nov 2, 2020 · Filed Dec 1, 2020 · $1,001 to $15,000
Federal contracts
GH contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GH in this window.
Lobbying spend
GH lobbying filings, year to date.
Registered lobbying filings matched to Guardant Health, Inc. Common Stock.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GH in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for GH.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.